HFM
KNSA icon

Harvest Fund Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Harvest Fund Management’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,903
Closed -$48K – 579
2020
Q2 		$48K Buy
+1,903
New +$39.8K ﹤0.01% 336

Other funds holding KNSA

HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Harvest Fund Management's KNSA Position: Q3 2020 in Review

Harvest Fund Management sold out of Kiniksa Pharmaceuticals (KNSA) in Q3 2020, closing a stake of 1,903 shares — an estimated $48K sold.

Harvest Fund Management first reported a position in KNSA in Q2 2020 and held it in 1 quarter. The position peaked at $48K in Q2 2020. 104 funds tracked by Wall St. Rank hold KNSA as of Q3 2020.

  • Harvest Fund Management reported no remaining Kiniksa Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Harvest Fund Management sold 1,903 Kiniksa Pharmaceuticals shares in Q3 2020, an estimated $48K.
  • Harvest Fund Management first reported a position in Kiniksa Pharmaceuticals in Q2 2020 and held it in 1 quarter.
  • Harvest Fund Management's Kiniksa Pharmaceuticals position peaked at $48K in Q2 2020.
  • 104 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q3 2020.

Based on Harvest Fund Management's 13F filing for Q3 2020, filed 4 Nov 2020.